These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 30275089)

  • 1. Emergence and Within-Host Genetic Evolution of Methicillin-Resistant
    Rouard C; Garnier F; Leraut J; Lepainteur M; Rahajamananav L; Languepin J; Ploy MC; Bourgeois-Nicolaos N; Doucet-Populaire F
    Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30275089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emergence of cfr-Mediated Linezolid Resistance in a Methicillin-Resistant Staphylococcus aureus Epidemic Clone Isolated from Patients with Cystic Fibrosis.
    de Dios Caballero J; Pastor MD; Vindel A; Máiz L; Yagüe G; Salvador C; Cobo M; Morosini MI; del Campo R; Cantón R;
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1878-82. PubMed ID: 26666940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-Host Emergence of Linezolid Resistance in a Complex Pattern of Toxic Shock Syndrome Toxin-1-Positive Methicillin-Resistant
    Boudet A; Jay A; Dunyach-Remy C; Chiron R; Lavigne JP; Marchandin H
    Toxins (Basel); 2021 Apr; 13(5):. PubMed ID: 33925199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linezolid-resistant ST36 methicillin-resistant Staphylococcus aureus associated with prolonged linezolid treatment in two paediatric cystic fibrosis patients.
    Hill RL; Kearns AM; Nash J; North SE; Pike R; Newson T; Woodford N; Calver R; Livermore DM
    J Antimicrob Chemother; 2010 Mar; 65(3):442-5. PubMed ID: 20089543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergence of linezolid-resistant Staphylococcus aureus after prolonged treatment of cystic fibrosis patients in Cleveland, Ohio.
    Endimiani A; Blackford M; Dasenbrook EC; Reed MD; Bajaksouszian S; Hujer AM; Rudin SD; Hujer KM; Perreten V; Rice LB; Jacobs MR; Konstan MW; Bonomo RA
    Antimicrob Agents Chemother; 2011 Apr; 55(4):1684-92. PubMed ID: 21263048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterisation of clinical meticillin-resistant Staphylococcus epidermidis demonstrating high levels of linezolid resistance (>256 μg/ml) resulting from transmissible and mutational mechanisms.
    Gabriel EM; Fitzgibbon S; Clair J; Coffey A; O'Mahony JM
    J Infect Chemother; 2015 Jul; 21(7):547-9. PubMed ID: 25913534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical, Bacteriological, and Genetic Characterization of Bone and Joint Infections Involving Linezolid-Resistant Staphylococcus epidermidis: a Retrospective Multicenter Study in French Reference Centers.
    Coustillères F; Renault V; Corvec S; Dupieux C; Simões PM; Lartigue MF; Plouzeau-Jayle C; Tande D; Lamoureux C; Lemarié C; Chenouard R; Laurent F; Lemaignen A; Bémer P;
    Microbiol Spectr; 2023 Jun; 11(3):e0419022. PubMed ID: 37133395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linezolid-resistant cfr-positive MRSA, Italy.
    Antonelli A; D'Andrea MM; Galano A; Borchi B; Brenciani A; Vaggelli G; Cavallo A; Bartoloni A; Giovanetti E; Rossolini GM
    J Antimicrob Chemother; 2016 Aug; 71(8):2349-51. PubMed ID: 27073268
    [No Abstract]   [Full Text] [Related]  

  • 9. Novel ribosomal mutations in Staphylococcus aureus strains identified through selection with the oxazolidinones linezolid and torezolid (TR-700).
    Locke JB; Hilgers M; Shaw KJ
    Antimicrob Agents Chemother; 2009 Dec; 53(12):5265-74. PubMed ID: 19752277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linezolid-resistant Staphylococcus aureus strain 1128105, the first known clinical isolate possessing the cfr multidrug resistance gene.
    Locke JB; Zuill DE; Scharn CR; Deane J; Sahm DF; Denys GA; Goering RV; Shaw KJ
    Antimicrob Agents Chemother; 2014 Nov; 58(11):6592-8. PubMed ID: 25155597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic management of methicillin-resistant Staphylococcus aureus--associated acute pulmonary exacerbations in cystic fibrosis.
    Fusco NM; Toussaint KA; Prescott WA
    Ann Pharmacother; 2015 Apr; 49(4):458-68. PubMed ID: 25583881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid Acquisition of Linezolid Resistance in Methicillin-Resistant Staphylococcus aureus: Role of Hypermutation and Homologous Recombination.
    Iguchi S; Mizutani T; Hiramatsu K; Kikuchi K
    PLoS One; 2016; 11(5):e0155512. PubMed ID: 27182700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial susceptibility and molecular typing of MRSA in cystic fibrosis.
    Champion EA; Miller MB; Popowitch EB; Hobbs MM; Saiman L; Muhlebach MS;
    Pediatr Pulmonol; 2014 Mar; 49(3):230-7. PubMed ID: 23765686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased copy number of 23S ribosomal RNA gene with point mutation in MRSA associated with linezolid resistance in a patient treated with long-term linezolid.
    Suzuki K; Saito M; Hanaki H
    J Infect Chemother; 2023 May; 29(5):481-484. PubMed ID: 36736701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergence of linezolid-resistant Staphylococcus aureus during treatment of pulmonary infection in a patient with cystic fibrosis.
    Gales AC; Sader HS; Andrade SS; Lutz L; Machado A; Barth AL
    Int J Antimicrob Agents; 2006 Apr; 27(4):300-2. PubMed ID: 16527459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virulence-suppressing effects of linezolid on methicillin-resistant Staphylococcus aureus: possible contribution to early defervescence.
    Yoshizawa S; Tateda K; Saga T; Ishii Y; Yamaguchi K
    Antimicrob Agents Chemother; 2012 Apr; 56(4):1744-8. PubMed ID: 22290944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linezolid-resistant Staphylococcus aureus isolated from 2006 through 2008 at six hospitals in Japan.
    Ikeda-Dantsuji Y; Hanaki H; Sakai F; Tomono K; Takesue Y; Honda J; Nonomiya Y; Suwabe A; Nagura O; Yanagihara K; Mikamo H; Fukuchi K; Kaku M; Kohno S; Yanagisawa C; Nakae T; Yoshida K; Niki Y
    J Infect Chemother; 2011 Feb; 17(1):45-51. PubMed ID: 20607345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telavancin demonstrates activity against methicillin-resistant Staphylococcus aureus isolates with reduced susceptibility to vancomycin, daptomycin, and linezolid in broth microdilution MIC and one-compartment pharmacokinetic/pharmacodynamic models.
    Smith JR; Barber KE; Hallesy J; Raut A; Rybak MJ
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5529-34. PubMed ID: 26124162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistence of rRNA operon mutated copies and rapid re-emergence of linezolid resistance in Staphylococcus aureus.
    Tsakris A; Pillai SK; Gold HS; Thauvin-Eliopoulos C; Venkataraman L; Wennersten C; Moellering RC; Eliopoulos GM
    J Antimicrob Chemother; 2007 Sep; 60(3):649-51. PubMed ID: 17623697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First Report of cfr-Carrying Plasmids in the Pandemic Sequence Type 22 Methicillin-Resistant Staphylococcus aureus Staphylococcal Cassette Chromosome mec Type IV Clone.
    Shore AC; Lazaris A; Kinnevey PM; Brennan OM; Brennan GI; O'Connell B; Feßler AT; Schwarz S; Coleman DC
    Antimicrob Agents Chemother; 2016 May; 60(5):3007-15. PubMed ID: 26953212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.